Prelude Therapeutics Incorporated (PRLD) Earnings
NASDAQ·Healthcare·Biotechnology
$4.88
+5.06%
Mkt Cap $252.78M
EPS — Estimate vs Actual
Mkt Cap
$252.78M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58
NASDAQ·Healthcare·Biotechnology
$4.88
+5.06%
Mkt Cap $252.78M
Mkt Cap
$252.78M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58